Botanical Adulteration in EU Cosmetics Ingredients: Why Your Supplier's CoA Is Not Identity Verification

In 2013, researchers published a DNA barcoding analysis of 44 commercial herbal products purchased from retail pharmacies in Canada. Fifty-nine percent contained plant species that weren’t listed on the label. Nearly a third had been substituted with material from an entirely different genus. The finding wasn’t a fringe result — it appeared in BMC Medicine, a peer-reviewed journal, authored by botanists at the University of Guelph.

That study covered supplements. But if you’re sourcing botanical ingredients for EU cosmetics or food supplements, the supply chain dynamics it revealed haven’t changed. If anything, demand pressure on high-value botanicals — argan, rosehip, bakuchiol, centella asiatica, black cohosh — has deepened the economic incentive to adulterate. Supply shortfalls in a single growing season for a popular botanical can multiply adulteration risk across an entire category within months.

Most European manufacturers believe their supplier’s Certificate of Analysis handles this. It doesn’t.

Adulteration Is More Systematic Than Most Manufacturers Assume

The American Botanical Council’s Botanical Adulterants Prevention Program (BAPP) — the most comprehensive industry database of its kind — has catalogued documented adulteration cases across more than 60 high-volume botanical commodities. The list reads like a register of ingredients found in any natural cosmetics catalogue: lavender essential oil, aloe vera, arnica, chamomile, rosehip seed oil, turmeric extract, ginkgo biloba.

The mechanisms vary considerably. Some adulteration is straightforward substitution — a cheaper related species in place of the stated botanical. Lavender essential oil (Lavandula angustifolia) is routinely adulterated with lavandin (Lavandula × intermedia) or synthetic linalool/linalyl acetate blends; the cost differential can reach 60 to 70% per kilogram at commercial volumes. Turmeric extracts are increasingly supplied with curcumin isolated from other Curcuma species or, in more egregious cases, supplemented with synthetic curcumin analogues that register identically in simple HPLC assays targeting curcuminoid content.

Other adulteration is more subtle: partial dilution of genuine material with fillers (maltodextrin in powdered extracts, carrier oils in liquid extracts), deliberate concentration of inactive marker compounds while depleting the authentic active fractions, or species blending — where genuine botanical material is present but constitutes only 20 to 30% of the batch by mass. The economic logic is consistent: genuine botanical material is expensive, supply is variable, and the tests that buyers typically run don’t detect the fraud.

None of these substitutions are reliably caught by a standard CoA.

What EU Regulation 1223/2009 Actually Requires — and Where It Goes Silent

Under Article 10 of EU Regulation 1223/2009, every cosmetic product placed on the EU market must be supported by a Cosmetic Product Safety Report (CPSR). Part A of the CPSR requires a qualitative and quantitative composition of the product, including the identity of each ingredient — stated using the INCI name and CAS number, with purity data where available.

The regulation doesn’t specify how that identity must be confirmed.

That gap is significant. In practice, many Responsible Persons (RPs) satisfy the CPSR composition section by reproducing the supplier’s specification sheet and CoA. The CoA typically confirms heavy metal levels, pesticide residue, microbial counts, moisture content, and — for extracts — one or two marker compound concentrations via HPLC. These are quality parameters. They are not identity tests.

The European Pharmacopoeia (Ph.Eur.), published by EDQM, offers the relevant standard. Ph.Eur. monographs for botanical substances specify identity tests that typically include macroscopic and microscopic description, HPTLC fingerprinting, and in some cases thin-layer chromatography with reference standards. These tests are designed specifically to discriminate authentic material from adulterants. But Ph.Eur. compliance is mandatory for medicinal products — not for cosmetic ingredients. For food supplements sold across the EU, EU Directive 2002/46/EC harmonises vitamins and minerals but leaves botanical ingredients largely unharmonised at the member state level. France’s DGCCRF has historically enforced ingredient quality through post-market product inspections, but systematic pre-market botanical identity testing at the ingredient level is not a universal requirement anywhere in the bloc.

The result: botanical ingredient adulteration can persist through supply chains serving both the cosmetics and food supplement sectors without ever triggering a regulatory flag — until a product recall, a contested CPSR, or a consumer complaint forces the issue.

The CoA Problem: What a Certificate of Analysis Actually Confirms

Relying on a CoA for botanical identity is like using a bathroom scale to diagnose a broken bone. The instrument simply isn’t designed for the question you’re asking.

A standard CoA confirms the quantity of specified analytes — marker compounds, contaminants, moisture. It confirms that a material meets a pre-agreed specification. But that specification was written, in most cases, by the same supplier issuing the CoA. If the specification doesn’t include an HPTLC fingerprint or a DNA-based identity test, the CoA provides no protection against substitution or blending.

Consider rosehip seed oil, a staple in anti-ageing formulations. A CoA will confirm fatty acid profile via GC, including expected levels of linoleic acid (typically 44–49%) and linolenic acid (33–38%) for genuine Rosa canina seed oil. The problem: closely related Rosa species, and even some seed oils from botanically unrelated plants, can produce a fatty acid profile that falls within these ranges. Standard GC cannot distinguish R. canina from R. moschata, R. rubiginosa, or a deliberate blend. A stable isotope ratio analysis (IRMS) or a full botanical identity protocol is required.

The same limitation applies across dozens of high-value ingredients: argan oil (frequently blended with other cosmetic oils at scale), centella asiatica (species substitution), St. John’s Wort extract (variable species and extraction fractions between batches), ginkgo biloba (synthetic flavonoid addition to inflate marker compound readings while depleting authentic ginkgolides). In each case, the CoA passes. The material fails.

Three Methods That Actually Verify Botanical Identity

There is no single universal method. Authoritative botanical identity verification typically combines two or three complementary approaches, each working from a different analytical principle.

HPTLC (High-Performance Thin-Layer Chromatography) is the workhorse of Ph.Eur. botanical monographs. It produces a characteristic chromatographic fingerprint — a pattern of bands at specific Rf values — that reflects the full secondary metabolite profile of the material. Unlike HPLC, which targets specific pre-selected analytes, HPTLC captures the chemical complexity of the whole extract. A skilled analyst comparing sample and reference standard chromatograms can identify substitution, dilution, or adulteration with high specificity. CAMAG, the Swiss instrumentation company, has validated HPTLC methodology for more than 150 botanical species in collaboration with EDQM and USP — and the methods are publicly available. But running them requires validated equipment, certified reference standards, and trained analysts. That combination is far less common in European routine testing labs than the regulatory environment might suggest.

DNA Barcoding works from an entirely different principle. Short, standardised genomic regions — typically the ITS2 nuclear region or the psbA-trnH plastid region — serve as species-specific sequences that can be amplified, sequenced, and matched against curated reference databases. The technique identifies the botanical species present regardless of how the material has been processed, and it is not susceptible to the chemical mimicry that defeats marker compound methods. It is now incorporated as a reference method in several USP botanical monographs. The important limitation: highly refined extracts and isolates can degrade DNA to the point where amplification fails, so applicability depends on the processing level of the ingredient.

LC-MS/MS (Liquid Chromatography–Tandem Mass Spectrometry) provides targeted profiling of specific compound classes — alkaloids, terpenoids, phenolic acids, flavonoids — and can detect adulterants that are absent from the expected metabolite profile even when present at low concentrations. For botanicals with complex alkaloid chemistry (black cohosh, kava, valerian, kratom), LC-MS/MS can reliably distinguish authentic species from substitutes that produce a superficially similar marker compound profile under simpler HPLC methods.

Most European contract laboratories operate standard HPLC, GC, and wet chemistry platforms for raw material testing. HPTLC with reference-standard comparison, DNA barcoding, and LC-MS/MS botanical profiling represent a genuinely small subset of available capabilities in the EU — which is why a number of European manufacturers have begun partnering with North American laboratories where this expertise is more established and routinely applied.

The Five Botanicals That Warrant Immediate Scrutiny

Not every botanical ingredient in your formulation carries equal adulteration risk. Prioritising testing resources against the highest-risk materials is a practical starting point.

Lavender essential oil — Adulteration with lavandin or synthetic linalool/linalyl acetate blends is endemic at commercial scale. Chiral GC (measuring enantiomeric ratios of linalool) is more discriminating than standard GC-FID but is still not universally applied by suppliers or buyers.

Aloe vera — A 2018 analysis published in Food Control found that approximately 44% of commercial aloe vera product samples contained no detectable acemannan, the authentic marker polysaccharide. Many had been replaced with starch-thickened water or diluted to sub-functional concentrations.

Rosehip seed oil — As noted, fatty acid profile alone is insufficient. Phytosterol profiling and stable isotope analysis add meaningful discriminatory power and are worth specifying in supplier agreements for high-volume purchases.

Turmeric (curcumin) extract — Curcuminoid content by HPLC does not distinguish authentic Curcuma longa extracts from synthetic curcumin addition. A full secondary metabolite fingerprint via HPTLC or LC-MS reveals the difference clearly.

Black cohosh (Actaea racemosa) — Used in cosmetics for skin-soothing applications and in supplements for hormonal support claims. Asian Actaea species (notably A. cimicifuga and A. dahurica) are regularly substituted at source. DNA barcoding is the most reliable discriminator, and it’s the method HMPC at EMA has endorsed for species confirmation in herbal monograph documentation.

What a Proportionate Response Actually Looks Like

The answer isn’t to distrust every supplier or to demand three-method identity testing on every incoming material. It’s to apply verification methodology that is proportionate to the risk profile of the ingredient.

For high-volume, lower-cost botanicals with limited adulteration incentive and a clean industry track record, a well-constructed specification and periodic CoA review may be sufficient. For high-value, high-demand ingredients — particularly those with documented adulteration histories in BAPP bulletins or Ph.Eur. monograph advisory notes — HPTLC fingerprinting against a certified reference standard should be a minimum condition for incoming material release. For ingredients going into products carrying specific efficacy claims, DNA barcoding adds a further layer of confirmable evidence.

The investment is modest relative to the cost of a RAPEX notification, a product reformulation triggered by a failed safety assessment, or a class action in a territory where ingredient claims are taken literally. For cosmetic Responsible Persons preparing CPSRs under Article 10, documented botanical identity verification also strengthens the scientific dossier considerably — and safety assessors are increasingly aware of the difference between “we have a CoA” and “we have verified identity.”

Access to this level of testing in Europe remains genuinely uncommon. If your current testing provider’s botanical offering begins and ends with marker compound HPLC, it’s worth knowing what you’re not seeing.

---

Written by Nour Abochama, Quality & Regulatory Advisor, Care Europe | VP Operations, Qalitex. Learn more about our team

Talk to our team about EU market entry. Contact us

Related from our network

• Botanical Identity Testing and HPTLC Fingerprinting for Raw Materials — ISO 17025-accredited botanical identity verification, including HPTLC, DNA barcoding, and LC-MS/MS profiling for cosmetic and supplement ingredients in the US market.
• Botanical Identity Testing for Canadian NHP Licence Applications — Health Canada-compliant botanical authentication for NHP product licence dossiers, including species confirmation and adulteration screening.